Our results suggest that SLB procedures (such as VATS lung biopsy) should be the procedure of choice for obtaining tissue samples for diagnosis, subtyping, and EGFR analysis in patients with a lung lesion in whom lung cancer is suspected. This evidence concerns the gene EGFR and lung carcinoma.